Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2016 | 1 |
2018 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963.
N Engl J Med. 2023.
PMID: 37133585
Clinical Trial.
Imatinib-induced bone edema: case report and review of literature.
dos Santos LV, Lima JP, Abdalla KC, Bragagnoli AC, Santos FA, dos Anjos Jácome A, Porto FE.
dos Santos LV, et al. Among authors: abdalla kc.
J Natl Compr Canc Netw. 2013 Oct 1;11(10):1187-91. doi: 10.6004/jnccn.2013.0140.
J Natl Compr Canc Netw. 2013.
PMID: 24142819
Review.
Item in Clipboard
Timing of adjuvant chemotherapy in colorectal cancer.
Dos Santos LV, Faria TM, Lima AB, Abdalla KC, de Moraes ED, Cruz MR, Lima JP.
Dos Santos LV, et al. Among authors: abdalla kc.
Colorectal Dis. 2016 Sep;18(9):871-6. doi: 10.1111/codi.13306.
Colorectal Dis. 2016.
PMID: 26900665
Item in Clipboard
Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial.
Bragagnoli AC, Araujo RLC, Ferraz MW, Dos Santos LV, Abdalla KC, Comar F, Santos FA, Oliveira MA, Carvalheira JBC, Cárcano FM, da Silveira Nogueira Lima JP.
Bragagnoli AC, et al. Among authors: abdalla kc.
Br J Cancer. 2021 Mar;124(6):1072-1078. doi: 10.1038/s41416-020-01208-6. Epub 2021 Jan 4.
Br J Cancer. 2021.
PMID: 33398062
Free PMC article.
Clinical Trial.
Item in Clipboard
Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.
Romera A, Peredpaya S, Shparyk Y, Bondarenko I, Mendonça Bariani G, Abdalla KC, Roca E, Franke F, Melo Cruz F, Ramesh A, Ostwal V, Shah P, Rahuman SA, Paravisini A, Huerga C, Del Campo García A, Millán S.
Romera A, et al. Among authors: abdalla kc.
Lancet Gastroenterol Hepatol. 2018 Dec;3(12):845-855. doi: 10.1016/S2468-1253(18)30269-3. Epub 2018 Sep 24.
Lancet Gastroenterol Hepatol. 2018.
PMID: 30262136
Clinical Trial.
Item in Clipboard
Cite
Cite